2006The FASEB JournalRequires access

Fluctuation of the dopamine uptake inhibition potency of cocaine, but not amphetamine, in CHO cells stably transfected with the dopamine transporter

Suneetha Ramanujapuram, Okechukwu Ukairo, Christopher K. Surratt

Open publisher page 1 citations

Abstract

Cocaine, amphetamines and other psychostimulants inhibit synaptic dopamine (DA) uptake by interfering with dopamine transporter (DAT) function. The resultant potentiation of dopaminergic neurotransmission is associated with psychostimulant addiction. We previously reported fluctuations in dopamine uptake inhibition potency (DUIP) at different cell passages (“low”, “medium” and “high”) of wild type (WT) DAT CHO cells for classical DAT blockers including cocaine and methylphenidate. In the present study, the DAT substrate D‐amphetamine did not display this DUIP fluctuation. For all drugs tested, no significant differences were observed in binding affinities at WT DAT (via displacement of [ 3 H]‐WIN 35,428) as a function of cell passage. DAT expression (reported by B max values) was subtly altered by cell passage, but DA turnover number was unaffected. It is currently unclear why DUIPs, but not apparent binding affinities, fluctuate for the classic DAT blockers, or why D‐amphetamine does not exhibit this fluctuation. The fact that amphetamine diverges from this DAT blocker pharmacologic profile is consistent with the idea of fundamental differences between the mechanisms of abused psychostimulant DAT substrates and inhibitors. Funding was provided by NIDA grants DA16604 and DA16604‐01S1 (to C.K.S)

About this research paper

What this paper is about

Cocaine, amphetamines and other psychostimulants inhibit synaptic dopamine (DA) uptake by interfering with dopamine transporter (DAT) function. The resultant potentiation of dopaminergic neurotransmission is associated with psychostimulant addiction. We previously reported fluctuations in dopamine uptake inhibition potency (DUIP) at different cell passages (“low”, “medium” and “high”) of wild type (WT) DAT CHO cells for classical DAT blockers including cocaine and methylphenidate. In the present study, the DAT substrate D‐amphetamine did not display this DUIP fluctuation. For all drugs tested, no significant differences were observed in binding affinities at WT DAT (via displacement of [ 3 H]‐WIN 35,428) as a function of cell passage. DAT expression (reported by B max values) was subtly altered by cell passage, but DA turnover number was unaffected. It is currently unclear why DUIPs, but not apparent binding affinities, fluctuate for the classic DAT blockers, or why D‐amphetamine does not exhibit this fluctuation. The fact that amphetamine diverges from this DAT blocker pharmacologic profile is consistent with the idea of fundamental differences between the mechanisms of abused psychostimulant DAT substrates and inhibitors. Funding was provided by NIDA grants DA16604 and DA16604‐01S1 (to C.K.S)

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Cocaine, amphetamines and other psychostimulants inhibit synaptic dopamine (DA) uptake by interfering with dopamine transporter (DAT) function. The resultant potentiation of dopaminergic neurotransmission is associated with psychostimulant addiction. We previously reported fluctuations in dopamine uptake inhibition potency (DUIP) at different cell passages (“low”, “medium” and “high”) of wild type (WT) DAT CHO cells for classical DAT blockers including cocaine and methylphenidate. In the present study, the DAT substrate D‐amphetamine did not display this DUIP fluctuation. For all drugs tested, no significant differences were observed in binding affinities at WT DAT (via displacement of [ 3 H]‐WIN 35,428) as a function of cell passage. DAT expression (reported by B max values) was subtly altered by cell passage, but DA turnover number was unaffected. It is currently unclear why DUIPs, but not apparent binding affinities, fluctuate for the classic DAT blockers, or why D‐amphetamine does not exhibit this fluctuation. The fact that amphetamine diverges from this DAT blocker pharmacologic profile is consistent with the idea of fundamental differences between the mechanisms of abused psychostimulant DAT substrates and inhibitors. Funding was provided by NIDA grants DA16604 and DA16604‐01S1 (to C.K.S)

Key concepts: Dopamine transporter, Amphetamine, Dopamine, Dopaminergic, Dopamine Plasma Membrane Transport Proteins, Mazindol, Chemistry, Pharmacology

Related papers

Back to paper searchBrowse research topicsOriginal source
Fluctuation of the dopamine uptake inhibition potency of cocaine, but not amphetamine, in CHO cells stably transfected with the dopamine transporter — Research Paper | ScholarLens